Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CB-183
CB-183
Cubist plans late-stage studies of diarrhea drug
Yahoo/AP
Fri, 09/30/11 - 11:00 am
Cubist
diarrhea
CB-183
315
Clostridium Difficile